Back

Current evidence for tricuspid repair across HF subtypes.

28 August 2022 (18:13 - 18:20)
Organised by:
Congress Presentation Part of: HFpEF vs. HFrEF in patients with tricuspid regurgitation: does it matter for TTVr? Valvular Heart Disease Open Access ESC Congress 2022

About the speaker

Photo
Doctor Karl-Patrik Kresoja

University Medical Centre of the Johannes Gutenberg University, Mainz (Germany)

5 More presentations in this session

Presentation thumbnail
Heart failure diagnosis & management beyond HFrEF in 2022.
Professor C. Lam (Singapore, SG)
Slides Video
Presentation thumbnail
Tricuspid regurgitation (TR) and the right ventricle.
Professor J. Bax (Leiden, NL)
Slides Video
Presentation thumbnail
Is TR different across HF subtypes? (HFrEF).
Professor A. Stewart Coats (Sydney, AU)
Slides Video
Presentation thumbnail
Is TR different across HF subtypes? (HFpEF).
Professor B. Borlaug (Rochester, US)
Video
Presentation thumbnail
Open panel discussion.
Professor S. Anker (Berlin, DE) Professor C. Lam (Singapore, SG) Professor J. Bax (Leiden, NL) Professor A. Stewart Coats (Sydney, AU) Professor B. Borlaug (Rochester, US) Doctor K. Kresoja (Mainz, DE)
Video

Access the full session

Session thumbnail
HFpEF vs. HFrEF in patients with tricuspid regurgitation: does it matter for TTVr?
Video

The Event

Event poster

ESC Congress 2022

28 August 2022 18:13 CET
You may be interested in
thumbnail
Congress Presentation
Hemodynamic implications of transcatheter tricuspid valve repair in HFpEF Patients - HERACLES-HFpEF
thumbnail
Congress Presentation
HFpEF: what is the status quo?
thumbnail
Congress Presentation
Transcatheter-edge-to-edge-repair of functional mitral regurgitation in advanced HFrEF: the impact of intrinsic left ventricular performance on the degree of MR reduction and clinical outcome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources